How research evolves and brings new hope to patients

Before medicines can be made available to patients, they often begin as ideas that are based on newly discovered molecules and cells, strange phenomena or little-understood processes in the body. The biopharmaceutical industry ’s unique role in theresearch ecosystem is to utilize its scientific, medical and industrial expertise to take the necessary risks to build on and translate basic scientific research into safe and effective medicines that can be made available to patients. This long and complex process is regularly fraught with more setbacks than successes asless than 12% of medicines entering phase one clinical trials ever end up as U.S Food and Drug Administration (FDA) approved medicine. Setbacks in research are natural for all researchers who take each failure and use them to inform future success, and Alzheimer ’s disease is no exception. 
Source: The Catalyst - Category: Pharmaceuticals Tags: Research and Development Alzheimer's Source Type: news